Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose.
One of those cases where knowing the mechanism does not help the decision.
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose.
One of those cases where knowing the mechanism does not help the decision.
Post #30 answers the question as asked. The question underneath it is different.
Offering a way to settle appeal rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise, the question was not answerable at this precision.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
Worth separating two things that post #32 runs together.
I have three months of notes on appeal and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion from the first fortnight.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
Reframing appeal slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often", nobody here knows.
Picking up post #38: that is the part I would want checked first.
The documentation on appeal is better than this thread and I say that as someone who has posted in the thread.
Appeal looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Answering the question post #41 raises rather than the one it answers.
Where I would push back on the appeal consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
The arithmetic in post #41 is right; the assumption feeding it is the part to check.
Small methodological point on appeal: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
Building on post #45 rather than restating it.
Careful with the language on appeal. "Not detected" and "not present" are different findings and the first is a statement about the method.
Coming back to post #45, because the follow-up matters more than the original answer.
An update on my earlier appeal post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
I have said this before in a thread nobody could find, so it is worth repeating.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
Agreed, and I will stop repeating the version of this I had been repeating.
The reason appeal is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Where I part company with post #59, and it is a narrow parting.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
That is the version I would defend. It is not the version I started with.